Outdoor walking training versus cycle ergometer training during inpatient rehabilitation in COPD patients GOLD stages III to IV. A feasibility randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00010977

Enrollment

Registered

2016-11-21

Start date

2016-07-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD GOLD stage III und IV J44

Interventions

Group 1: The intervention group received the interval Outdoor Walking Training four times weekly for 3 weeks. Walking aids were allowed. The training took place under all weather conditions, includin

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: We intend to include patients with stable COPD GOLD III to IV (no acute exacerbation) during 3 weeks inpatient rehabilitation. Main inclusion criteria are the ability to walk 150m, the ability to ride a cycle ergometer (25 Watt) and to speak/read German.

Exclusion criteria

Exclusion criteria: Main exclusion criteria are physically limiting musculoskeletal, cardial disease and uncontrolled Hypertension, which make participation impossible.

Design outcomes

Primary

Measure	Time frame
The primary outcome, the feasibility of outdoor walking training in severe COPD patients and the study design, will be measured during the whole study. The feasibility factors are measured by reasons for exclusion (counting), recruitment rate (counting), reasons for drop outs (interview), follow up rate (counting), Patients and physiotherapists satisfaction (questionnaire), intensity of the training method (evaluation of the training protocol, especially the heartbeat frequency), missing data (training protocol), estimate sample size for a future study (calculating with Gpower 3.1).	—

Measure

Time frame

The primary outcome, the feasibility of outdoor walking training in severe COPD patients and the study design, will be measured during the whole study. The feasibility factors are measured by reasons for exclusion (counting), recruitment rate (counting), reasons for drop outs (interview), follow up rate (counting), Patients and physiotherapists satisfaction (questionnaire), intensity of the training method (evaluation of the training protocol, especially the heartbeat frequency), missing data (training protocol), estimate sample size for a future study (calculating with Gpower 3.1).

—

Secondary

Measure	Time frame
Main secondary outcomes are the health-related quality of life, measured by the chronic respiratory questionnaire (CRQ) and physical capacity, measured by the six minute walking test (6MWT). The patients receive the CRQ at admission, after 3 weeks and 3 month follow up. The physical capacity will be measured with the 6MWT at admission and after 3 weeks. We like to investigate the minimal important difference of the 6MWT and whether the different groups achieve a different cut off. Therefore we check the protocol of the 6MWT.The physical activity will be investigated with an activity tracker (Fitbit one). The patients will wear it 5 day in the last week in the rehabilitation and other 5 days after 3 month follow up (send it at home with an envelope for sending it back). To investigate the frequency of exacerbation, we will assessed it by telephone interview after 3 month follow up.	—

Measure

Time frame

Main secondary outcomes are the health-related quality of life, measured by the chronic respiratory questionnaire (CRQ) and physical capacity, measured by the six minute walking test (6MWT). The patients receive the CRQ at admission, after 3 weeks and 3 month follow up. The physical capacity will be measured with the 6MWT at admission and after 3 weeks. We like to investigate the minimal important difference of the 6MWT and whether the different groups achieve a different cut off. Therefore we check the protocol of the 6MWT.The physical activity will be investigated with an activity tracker (Fitbit one). The patients will wear it 5 day in the last week in the rehabilitation and other 5 days after 3 month follow up (send it at home with an envelope for sending it back). To investigate the frequency of exacerbation, we will assessed it by telephone interview after 3 month follow up.

—

Countries

Switzerland

Contacts

Public ContactEsther Gamper

Kliniken Valens, Rehazentrum Walenstadtberg

esther.gamper@bluewin.ch+41795810610

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 22, 2026